These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 36093542)
1. The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation. Yin Y; Li D; He M; Wang J Transl Cancer Res; 2022 Aug; 11(8):2622-2635. PubMed ID: 36093542 [TBL] [Abstract][Full Text] [Related]
2. Prognostic biomarkers and immune cell infiltration characteristics in small cell lung cancer. Ni J; Si X; Wang H; Zhang X; Zhang L Cancer Pathog Ther; 2023 Jan; 1(1):18-24. PubMed ID: 38328611 [TBL] [Abstract][Full Text] [Related]
3. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis. Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis. Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076 [TBL] [Abstract][Full Text] [Related]
5. Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis. Ni M; Liu X; Wu J; Zhang D; Tian J; Wang T; Liu S; Meng Z; Wang K; Duan X; Zhou W; Zhang X Front Genet; 2018; 9():469. PubMed ID: 30369945 [No Abstract] [Full Text] [Related]
6. Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis. Zeng Y; Li N; Chen R; Liu W; Chen T; Zhu J; Zeng M; Cheng J; Huang J Transl Cancer Res; 2020 Nov; 9(11):7149-7164. PubMed ID: 35117319 [TBL] [Abstract][Full Text] [Related]
7. Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis. Cui S; Lou S; Feng J; Tang X; Xiao X; Huang R; Guo W; Zhou Y; Huang F Transl Cancer Res; 2022 Apr; 11(4):710-724. PubMed ID: 35571642 [TBL] [Abstract][Full Text] [Related]
8. Survival-based bioinformatics analysis to identify hub genes and key pathways in non-small cell lung cancer. Liu C; Chen Y; Deng Y; Dong Y; Jiang J; Chen S; Kang W; Deng J; Sun H Transl Cancer Res; 2019 Aug; 8(4):1188-1198. PubMed ID: 35116861 [TBL] [Abstract][Full Text] [Related]
9. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
10. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
11. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling. Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481 [TBL] [Abstract][Full Text] [Related]
12. Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis. Liu H; Li T; Ye X; Lyu J Biomed Res Int; 2021; 2021():5953386. PubMed ID: 34712733 [TBL] [Abstract][Full Text] [Related]
13. Identification of key candidate tumor biomarkers in non-small-cell lung cancer by Chen W; Zhu S; Zhang Y; Xiao J; Tian D Oncol Lett; 2020 Jan; 19(1):1008-1016. PubMed ID: 31897214 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
15. Identification of significant genes in non-small cell lung cancer by bioinformatics analyses. Ye X; Gao Q; Wu J; Zhou L; Tao M Transl Cancer Res; 2020 Jul; 9(7):4330-4340. PubMed ID: 35117799 [TBL] [Abstract][Full Text] [Related]
16. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer. Liu X; Liu X; Li J; Ren F Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030 [TBL] [Abstract][Full Text] [Related]
17. Identification of Key Genes and Signaling Pathways in Entrectinibresistant Non-small Cell Lung Cancer Using Bioinformatic Analysis and Experimental Verification. Chen X; Zhao X; Li D; Zha W Curr Med Chem; 2024 Aug; ():. PubMed ID: 39108112 [TBL] [Abstract][Full Text] [Related]
18. Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis. Dong S; Liang J; Zhai W; Yu Z Mol Genet Genomic Med; 2020 Mar; 8(3):e1126. PubMed ID: 31981472 [TBL] [Abstract][Full Text] [Related]
19. Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer. Jian L; Yang G Diabetes Metab Syndr Obes; 2020; 13():463-476. PubMed ID: 32110079 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related] [Next] [New Search]